StockData
Korsana Biosciences, Inc. logo

Korsana Biosciences, Inc. (KRSA) stock

KRSANasdaqPharmaceutical PreparationsFiscal year ends December 31
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Nov 5, 2026Score 6/30493% above fair value
$32.50−0.18 (-0.55%)

Close on Nov 17, 2026Market cap $152.14MP/E –Yield –

Korsana Biosciences price to book ratio

The price-to-book ratio is market cap divided by shareholders' equity.

Korsana Biosciences's price to book ratio was 8.5× on Jan 31, 2025, against 4.0× a year earlier. Over the last 5 years it ranged from 2.9× to 20.1×, with a median of 9.1×.

Price to Book Ratio at the end of each year

PeriodPeriod endValueChange (pts)
2025Jan 31, 20258.5×+1.5
2024Dec 31, 20247.0×+2.5
2023Dec 29, 20234.5×−7.6
2022Dec 30, 202212.1×+2.8
2021Dec 31, 20219.2×−0.4
2020Dec 31, 20209.7×+5.3
2019Dec 31, 20194.4×–

More Korsana Biosciences figures

See a number that looks wrong?